Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic

Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic

Abstract As of today, there is no antiviral for the treatment of the SARS-CoV-2 infection, and the development of a vaccine might take several months or even years. The structural superposition of the hepatitis C virus polymerase bound to sofosbuvir, a nucleoside analog antiviral approved for hepati...

Full description

Saved in:
Bibliographic Details
Main Authors: Rodrigo Jácome, José Alberto Campillo-Balderas, Samuel Ponce de León, Arturo Becerra, Antonio Lazcano
Format: article
Language:EN
Published: Nature Portfolio 2020
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/27f5e92cc72e48598ae0a79c08b15f67
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items